Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

ClinicalTrials.gov ID: NCT01461837

Public ClinicalTrials.gov record NCT01461837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Familial Haploidentical T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (IND 14359)

Study identification

NCT ID
NCT01461837
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
New York Medical College
Other
Enrollment
21 participants

Conditions and interventions

Interventions

  • CD34 selected T-cell depleted allogeneic SCT Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2011
Primary completion
Nov 30, 2025
Completion
Nov 30, 2026
Last update posted
Aug 7, 2025

2012 – 2026

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of California Los Angeles (UCLA) Los Angeles California 90095
Children's Hospital and Research Center Oakland Oakland California 94609
Lurie Children's Hospital Chicago Illinois 60611-2605
Washington University/St. Louis Children's Hospital St Louis Missouri 63110
New York Medical College Valhalla New York 10595
Medical College of Wisconsin/Children's Hospital of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01461837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01461837 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →